Subscribe To
Gossamer bio: buying the savage dip after a trial 'win' may be unwise
Gossamer Bio, Inc.'s lead candidate - Seralutinib, indicated for Pulmonary Arterial hypertension - met ...
December 8, 2022, 1:27 pm
Gossamer bio tumbles as hypertension drug underperforms rival product in phase 2 trial
Gossamer Bio Inc stock lost three quarters of its value today as the market questioned the performance of the company's experimental ...
December 6, 2022, 2:54 pm
Why is gossamer bio (goss) stock down over 70% today?
Gossamer Bio (NASDAQ: GOSS ) is one of the top-trending tickers on social media today, and its shares are plunging more than 70%. The company announce...
December 6, 2022, 10:51 am
Gossamer bio's stock falls 64% on findings for phase 2 study for hypertension drug
Shares of Gossamer Bio Inc. GOSS, +2.99% plunged 64.5% in premarket trading on Tuesday after Wall Street analysts questioned the performance of the co...
December 6, 2022, 8:19 am
Cincor (cinc) tanks due to dismal data on hypertension drug
CinCor (CINC) plummets as its phase II study, HALO, evaluating its lead candidate baxdrostat for hypertension<...
November 29, 2022, 1:32 pm
Cincor's hypertension drug misses primary endpoint in mid-stage study
Shares of CinCor Pharma Inc. CINC, +3.51% fell 41.6% in premarket trading on Monday after the company said its experimental ...
November 28, 2022, 8:52 am
Galectin: ability to potentially target unmet medical need
Results from the phase 3 NAVIGATE study using Belapectin for the treatment of patients with NASH Cirrhosis without esophageal varices are expected in ...
July 11, 2022, 4:16 pm
Cincor pharma begins patient dosing in midstage hypertension, kidney disease study
CinCor Pharma (NASDAQ: CINC) has dosed first patient in the figHTN-CKD Phase 2 clinical study of its drug candidate Baxdrostat (CIN-107) for the treat...
June 1, 2022, 12:20 pm
Pfizer recalls some lots of hypertension med due to potential cancer-causing impurity
Pfizer Inc (NYSE: PFE) voluntarily recalls Accuretic (quinapril HCl/hydrochlorothiazide) and two authorized generic versions due to the presence of...
March 22, 2022, 3:10 pm
Pfizer (pfe) recalls hypertension drug due to impurities
Pfizer (PFE) is recalling six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets and four lots of quinapril HCl/ hydrochl...
March 22, 2022, 12:02 pm
Cincor pharma to report fourth quarter and full year 2021 financial results and host conference call on march 22, 2022
BOSTON, March 15, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC), a clinical-stage biopharmaceutical company focused on developing its le...
March 15, 2022, 9:41 am
Beyond air shares fall as us launch of lungfit ph not expected in 2021
Beyond Air Inc (NASDAQ: XAIR) expects a delay in FDA approval for LungFit PH for persistent pulmonary hyper...
December 9, 2021, 1:28 pm
Beyond air shares fall as us launch of lungfit ph not expected in 2021
Beyond Air Inc (NASDAQ: XAIR) expects a delay in FDA approval for LungFit PH for persistent pulmonary hyper...
December 9, 2021, 1:28 pm
Beyond air shares fall as us launch of lungfit ph not expected in 2021
Beyond Air Inc (NASDAQ: XAIR) expects a delay in FDA approval for LungFit PH for persistent pulmonary hyper...
December 9, 2021, 1:28 pm
Dariohealth announces agreement with global employer for metabolic and musculoskeletal health solutions
NEW YORK, Oct. 7, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today an ...
October 7, 2021, 6:40 am
Dariohealth announces agreement with global employer for metabolic and musculoskeletal health solutions
NEW YORK, Oct. 7, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today an ...
October 7, 2021, 6:40 am
Dariohealth announces agreement with global employer for metabolic and musculoskeletal health solutions
NEW YORK, Oct. 7, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today an ...
October 7, 2021, 6:40 am